Iqbal J Hussain is General Counsel of Centessa Pharmaceuticals plc. Currently has a direct ownership of 105,386 shares of CNTA, which is worth approximately $2.91 Million. The most recent transaction as insider was on Nov 17, 2025, when has been sold 6,000 shares (Ordinary Shares) at a price of $27.64 per share, resulting in proceeds of $165,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
46.64% 12M change
Total Value Held $2.91 Million

IQBAL J HUSSAIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
SELL
Open market or private sale
$165,840 $27.64 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Nov 17 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Oct 15 2025
SELL
Open market or private sale
$134,460 $22.41 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Oct 15 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Sep 15 2025
SELL
Open market or private sale
$131,100 $21.85 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Sep 15 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Sep 10 2025
SELL
Open market or private sale
$440,000 $22.0 p/Share
20,000 Reduced 15.95%
105,386 Ordinary Shares
Sep 10 2025
BUY
Exercise of conversion of derivative security
$116,800 $5.84 p/Share
20,000 Added 13.76%
125,386 Ordinary Shares
Sep 09 2025
SELL
Open market or private sale
$400,200 $20.01 p/Share
20,000 Reduced 15.95%
105,386 Ordinary Shares
Sep 09 2025
BUY
Exercise of conversion of derivative security
$116,800 $5.84 p/Share
20,000 Added 13.76%
125,386 Ordinary Shares
Aug 15 2025
SELL
Open market or private sale
$103,380 $17.23 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Aug 15 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Jul 15 2025
SELL
Open market or private sale
$89,580 $14.93 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Jul 15 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Jun 24 2025
SELL
Open market or private sale
$168,240 $14.02 p/Share
12,000 Reduced 10.22%
105,386 Ordinary Shares
Jun 24 2025
BUY
Exercise of conversion of derivative security
$70,080 $5.84 p/Share
12,000 Added 9.27%
117,386 Ordinary Shares
May 01 2025
SELL
Open market or private sale
$4,354 $14.0 p/Share
311 Reduced 0.29%
105,386 Ordinary Shares
May 01 2025
BUY
Exercise of conversion of derivative security
$1,816 $5.84 p/Share
311 Added 0.29%
105,697 Ordinary Shares
Apr 28 2025
SELL
Open market or private sale
$29,140 $14.01 p/Share
2,080 Reduced 1.94%
105,386 Ordinary Shares
Apr 28 2025
BUY
Exercise of conversion of derivative security
$12,147 $5.84 p/Share
2,080 Added 1.9%
107,466 Ordinary Shares
Apr 25 2025
SELL
Open market or private sale
$50,526 $14.0 p/Share
3,609 Reduced 3.31%
105,386 Ordinary Shares
Apr 25 2025
BUY
Exercise of conversion of derivative security
$21,076 $5.84 p/Share
3,609 Added 3.21%
108,995 Ordinary Shares
Mar 17 2025
SELL
Open market or private sale
$98,700 $16.45 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
Mar 17 2025
BUY
Exercise of conversion of derivative security
$35,040 $5.84 p/Share
6,000 Added 5.11%
111,386 Ordinary Shares
Feb 18 2025
SELL
Open market or private sale
$98,880 $16.48 p/Share
6,000 Reduced 5.39%
105,386 Ordinary Shares
IJH

Iqbal J Hussain

General Counsel
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA